Intermittent & adaptive therapy, sensitivity analysis, tissue organization, CAR-T cells, and more. 
, , and
Spatial evolution, clonal co-occurrence, Bayesian calibration, autocrine signaling, population genetics, and much more
, , and
Vasculogenesis, spatial distribution models, precision dosing, collateral sensitivity, 2021 in review, and more.
, , and
Clinical Prediction Models, tumor-immune interactions, periodic adaptive cycles, fitness landscapes, and more
, , and
Immunotherapy modeling, pancreatic cancer, radiotherapy scheduling, digital twins, and more
, , and
Radiotherapy, physics-based modeling, resource competition, positive selection in healthy tissue, and more
, , and
Personalized radiotherapy, causality in cancer, nano-particle drug delivery, antifragility, drug resistance, hierarchical tissue organization
, , and
Adaptive therapy, translational modeling, immune-spatial patterns, model-informed drug development, fitness landscapes
, , and
Organoid environmental effects, classic growth models in humans, adaptive therapy, model-informed drug development, tumor-immune interactions
, , and
Collateral sensitivity, optimal control, persistent homology, non-genetic inheritance, uncertainty quantification, and more...
, , and
Radiation-immune dynamics, plasticity, cultivating computational biology, immunotherapy resistance hallmarks, metabolic scaling theory
, , and
Website re-design, intratumoral heterogeneity, spatial immunophenotypes, CAR T-cell, coexistence phenotypes, and more
, , and